To help, researchers studied the medical records of 2,500 children and teens. These young people had either:
- acute lymphoblastic leukemia (ALL) or
- acute myeloid leukemia (AML).
Researchers noticed patterns in which treatments worked best for different children. The researchers used statistics to create the new tool. This simple tool that can used by your doctor in clinic forecasts how likely it is that BMT will help, based on the child’s:
- age at BMT,
- how well leukemia treatments have worked so far, and
- makeup of leukemia cells, called cytogenetics (pronounced si-toe-jeh-NET-iks).
If the tool suggests that BMT won’t help a child, then they can get other treatments instead.
Keep in mind
Ask your doctor
- How might this Pediatric Disease Risk Index apply to my child?
- What are the possible treatments for my child?
- What are the possible harms and benefits?